Search results for special authority form isotretinoin

Schedule Online - Isotretinoin

https://www.pharmac.govt.nz/wwwtrs/ScheduleOnline.php?osq=Isotretinoin&code=C1001011688

<< Section B - Therapeutic Groups Online Pharmaceutical Schedule - August 2020 Antiacne Preparations Section B - Therapeutic Groups TG1 - Dermatologicals TG2 - Antiacne Preparations TG3 - Antiacne Preparations Isotretinoin        - Special Authority SA1475 -- Retail pharmacy Cap 5 mg Oratane...

notification-2014-08-29-various-pharmaceuticals.pdf

https://www.pharmac.govt.nz/assets/notification-2014-08-29-various-pharmaceuticals.pdf

pump and insulin pump consumables: access will be widened to include cystic fibrosis-related diabetes. Isotretinoin: some of the prescriber-related criteria will be amended or removed from the Special Authority, and the requirement for a trial of other available treatments prior to accessing...

27 May 2003

https://www.pharmac.govt.nz/assets/consultation-2014-07-25-various-pharmaceuticals.pdf

and insulin pump consumables: access would be widened to include cystic fibrosis-related diabetes; Isotretinoin: some of the prescriber-related criteria would be amended or removed from the Special Authority, and the requirement for a trial of other available treatments prior to accessing isotretinoin would...

SA1475.pdf

https://www.pharmac.govt.nz/2020/08/01/SA1475.pdf

: ............................................................... ............................................................................... ............................................................................... Fax Number: ........................................................ APPLICATION FOR SUBSIDY BY SPECIAL AUTHORITY PATIENT NHI...

Forms

https://www.pharmac.govt.nz/tools-resources/forms/

circumstances application form [PDF, 208 KB] Community forms Individual Special Authority forms All Special Authority forms in one document Hospital forms Individual HML restriction checklist forms All HML restriction checklist forms in one document Other forms Save Word forms to your computer before...

Schedule Online - Tretinoin

https://www.pharmac.govt.nz/wwwtrs/ScheduleOnline.php?osq=Tretinoin&code=C1001012286

<< Section B - Therapeutic Groups Online Pharmaceutical Schedule - August 2020 Antiacne Preparations Section B - Therapeutic Groups TG1 - Dermatologicals TG2 - Antiacne Preparations TG3 - Antiacne Preparations Isotretinoin        - Special Authority SA1475 -- Retail pharmacy Cap 5 mg Oratane...

27 May 2003

https://www.pharmac.govt.nz/assets/schedule-dispatch-2018-08.pdf

(p’code 2549301) Ferrous sulphate (Ferrograd) tab long-acting 325 mg (105 mg elemental) (p’code 2534819) Isotretinoin (Oratane) cap 5 mg – Special Authority – Retail pharmacy (p’code 2339161) Metoprolol tartrate (Metoprolol IV Mylan) inj 1 mg per ml, 5 ml vial (p’code 2550369) Nifedipine (Adefin...

Schedule SAForms

https://www.pharmac.govt.nz/wwwtrs/SAForms.php?view=chem

<< PHARMAC Services Special Authority Forms Applicants can download individual Special Authority applications forms below or: Download all Special Authority forms. View the Named Patient Pharmaceutical Assessment (NPPA) forms. Sector Services contact details For enquires regarding the processing...

Schedule SAForms

https://pharmac.govt.nz/wwwtrs/SAForms.php?rss

<< PHARMAC Services Special Authority Forms Applicants can download individual Special Authority applications forms below or: Download all Special Authority forms. View the Named Patient Pharmaceutical Assessment (NPPA) forms. Sector Services contact details For enquires regarding the processing...

schedule-dispatch-2014-10.pdf

https://www.pharmac.govt.nz/assets/schedule-dispatch-2014-10.pdf

consumables – amended Special Authority criteria Isotretinoin (Oratane) cap 10 mg and 20 mg – amended Special Authority criteria Levothyroxine (Mercury Pharma) tab 50 mcg and 100 mcg – amended chemical name and Stat dispensing reinstated Macrogol 3350 with potassium chloride, sodium bicarbonate...

Microsoft Word - schedule-dispatch-2018-10.docx

https://www.pharmac.govt.nz/assets/schedule-dispatch-2018-10.pdf

your contact details. New listings Aqueous cream (Boucher) crm 500 g (p’code 2555115) Azactidine (Azacitidine Dr Reddy’s) inj 100 mg vial – PCT only – Specialist – Special Authority (p’code 2550083) Betamethasone dipropionate with calcipotriol (Daivobet) gel 500 mcg with calcipotriol 50 mcg...

notification-2015-04-30-tender.pdf

https://www.pharmac.govt.nz/assets/notification-2015-04-30-tender.pdf

Subsidised Supply date (and delisting of other listed brands) 1 October 2015 1 December 2015 1 March 2016 3. The Special Authority restrictions will be removed from 1 November 2015. Brand switch fee of $4.33 is payable for this product from 1 March 2016 until 1 June 2016 4. The endorsement...

27 May 2003

https://www.pharmac.govt.nz/assets/schedule-dispatch-2015-10.pdf

your contact details. New listings Metformin hydrochloride (Metformin Mylan) tab immediate-release 850 mg (p’code 2479265) Pioglitazone (Vexazone) tab 15 mg (p’code 2479435), 30 mg (p’code 2479443) and 45 mg (p’code 2479451) Multivitamin renal (Clinicians Renal Vit) cap – Special Authority...

2w1f02_.DOC

https://www.pharmac.govt.nz/assets/ptac-minutes-2003-08.pdf

on the degree of response to treatment a patient was getting. The subcommittee considered that it would like to review the data provided in Special Authority forms (for both CML and GIST) on an annual basis. The subcommittee considered that a creation of a separate “Glivec panel” was not necessary...

Other exceptional circumstances forms

https://www.pharmac.govt.nz/tools-resources/forms/other-exceptional-circumstances-forms/

Other exceptional circumstances forms Other exceptions In addition to Special Authority forms and NPPA, we supply the following forms for use in specific circumstances: Paediatric oncology/haematology notification form [PDF, 342 KB] Prednisolone sodium phosphate oral liquid [PDF, 255 KB] Alpha...

CAC meeting

https://www.pharmac.govt.nz/assets/cac-minutes-2009-07.pdf

without special authority restrictions allowing it to be used for patients following a stroke and in patients who are intolerant or allergic to aspirin. Other matters The Committee noted that another brand of thyroxine (Synthroid) had been made available. The Committee discussed correspondence it had...

27 May 2003

https://www.pharmac.govt.nz/assets/schedule-dispatch-2015-09.pdf

2123495) – Special Authority – Retail pharmacy Mometasone furoate crm 0.1%, 15 g OP (p’code 218375) and 50 g OP (p’code 2395738) (Elocon Alcohol Free), and oint 0.1%, 15 g OP (p’code 218383) and 50 g OP (p’code 2395746) (Elocon) Cetomacrogol (healthE) crm BP, 500 g (p’code 2341050) Dimethicone...

form-funding-application.docx

https://www.pharmac.govt.nz/assets/form-funding-application.docx

that would provide the best health outcomes. We have written this funding application form for people, clinicians, clinical groups and consumer groups to use. We recognise that some individuals and groups won’t have the same resource as pharmaceutical suppliers to prepare applications. This form...

consultation-2015-11-06-special-foods.pdf

https://www.pharmac.govt.nz/assets/consultation-2015-11-06-special-foods.pdf

Supplements used as exclusive enteral nutrition: The Special Authority criteria would be amended to include the use of Standard Supplements for the treatment of Crohn’s disease in children. In addition, for liquid oral feed 1.5kcal/ml Standard Supplement when used as exclusive enteral nutrition...

ptac-minutes-2014-08.pdf

https://www.pharmac.govt.nz/assets/ptac-minutes-2014-08.pdf

medical practitioners to be vocationally registered or Nurse Practitioners to be working in a relevant scope of practice to apply for a pharmaceutical by Special Authority. The Committee recommended that the Special Authorities for acitretin and isotretinoin be amended to require applicants...

278401_.DOC

https://www.pharmac.govt.nz/assets/cac-minutes-2003-05.pdf

), Epilim (as a psychotropic medication), the removal of Special Authority on Olanzapine (short and long acting – when available), Cipramil dispersable 20mg tablet, Rosiglitazone for diabetes control. 7.2. 7.3. Members discussed whether it was the role of the committee to examine individual drugs. Members...

ptac-special-foods-subcommittee-minutes-2015-07.pdf

https://www.pharmac.govt.nz/assets/ptac-special-foods-subcommittee-minutes-2015-07.pdf

review 1.1 The Subcommittee noted that PHARMAC had received correspondence regarding the wording of both the ‘fat’ and ‘carbohydrate’ nutrient modules Special Authority criteria, specifically questioning whether the “and/or” before the last criterion. The comment had been made that using the word...

consultation-2017-08-03-products-to-be-tendered.xlsx

https://www.pharmac.govt.nz/assets/consultation-2017-08-03-products-to-be-tendered.xlsx

TRUE TRUE FALSE FALSE FALSE Special Authority restrictions may apply. A confidential rebate applies. Acarbose - Tab 100 mg TRUE 1,024,706 $ 88,575.59 $ 0.0864 FALSE TRUE TRUE FALSE FALSE FALSE Acarbose - Tab 50 mg TRUE 1,704,350 $ 81,058.89 $ 0.0476 FALSE TRUE TRUE FALSE FALSE FALSE Acetylcysteine...

tender-schedule-two-amended-2017-18.xlsx

https://www.pharmac.govt.nz/assets/tender-schedule-two-amended-2017-18.xlsx

FALSE FALSE Special Authority restrictions may apply. A confidential rebate applies. Acarbose - Tab 100 mg TRUE 1,039,256 $89,833 0.08644 FALSE TRUE TRUE FALSE FALSE Acarbose - Tab 50 mg TRUE 1,735,555 $82,543 0.04756 FALSE TRUE TRUE FALSE FALSE Acetylcysteine - Inj 200 mg per ml FALSE 2,511 $19,671...

CAC meeting

https://www.pharmac.govt.nz/assets/cac-minutes-2008-12.pdf

to prescribe isotretinoin and that the special authority mechanism would be used to monitor prescribing data. These General Practitioners will be required to indicate each time they prescribe that they are competent and able to prescribe the medication. PHARMAC staff advised the Committee of concerns that had...

Schedule Online - Special Foods

https://pharmac.govt.nz/wwwtrs/ScheduleOnline.php?code=A42

<< Section B - Therapeutic Groups Online Pharmaceutical Schedule - August 2020 Special Foods Section B - Therapeutic Groups Nutrient Modules Carbohydrate; Carbohydrate And Fat; Fat; Protein Oral Supplements/Complete Diet (Nasogastric/Gastrostomy Tube Feed) Diabetic Products; Fat Modified Products...

27 May 2003

https://www.pharmac.govt.nz/assets/consultation-2016-08-03-invitation-to-tender-medical-Schedule-Two.pdf

$482,762 $0.0423 C H 1% Crm 5% 300,608 $450,410 $1.4983 C H 1% Isotretinoin Cap 5 mg Ivermectin Cream 1% C H 1% C H 1% Not currently listed in the Pharmaceutical Schedule. Any listing may be subject to Special Authority restrictions. Not currently listed in the Pharmaceutical Schedule. Ketoconazole...

2020-21-ITT-Schedule-Two-products-to-be-tendered.xlsx

https://www.pharmac.govt.nz/assets/2020-21-ITT-Schedule-Two-products-to-be-tendered.xlsx

information on appropriate use available on a supplier's website. Preference for a blister pack. Special Authority restrictions may apply. Isotretinoin - Cap 20 mg TRUE 797,221 $ 136,125.49 $ 0.17 FALSE TRUE TRUE FALSE FALSE FALSE Preference for patient/clinician information on appropriate use available...

annual-review-2009.pdf

https://www.pharmac.govt.nz/assets/annual-review-2009.pdf

people expect because PTAC often asks for further information from a subcommittee. PTAC may also seek specific input from particular clinical groups – such as rheumatologists or gastroenterologists, particularly when we are developing a Special Authority for a particular medicine. As a matter...

ptac-special-foods-subcommittee-minutes-2014-02.pdf

https://www.pharmac.govt.nz/assets/ptac-special-foods-subcommittee-minutes-2014-02.pdf

at PHARMAC on 5 December 2013 1 Record of the previous Subcommittee meeting 1.1 The Subcommittee reviewed the minutes of its previous meeting held on 27 August 2012. 1.2 In relation to the discussion on the Special Authority initial application for extensively hydrolysed formula (section 6 - Hospital...